Indications to me is that the Nexus plant will have some 30 million+ in revenues over the next year... pretty sure the Horizon plant in Poland will go ahead that should bring 6 times the Nexus plant. To be built late spring and summer 2020. While the company is still largely under the radar because people are not aware of what "Isolate", the company major effort, is, and that many of the mass distributers have few producers of size and quality and are not aware of the cost for getting a sizable operation running that keeps small and most medium size competators from building a plant specifically capable for Isolate CBD.
The domination of 'pot socks' in that sector was a run of companies trying to grab as much of the market areas as possible and are now not profitable because of buying way overpriced operators, buildouts, 'door access' and are going to have some terrible write-downs for those assets- goodwill. Almost all the 'pot' leaders will not be profitable till 2022- and more dilutions of company values as to their stocks.
Operating profits are coming to the forefront of concerns for the Pot stocks...
meanwhile on the CBD side of Cannabis and Isolate and even 'syrup'/honey' production hasn't the mass employee to production cost or other expenses and taxations 'Pot" has.
Imo, inevitably the specializing in just a couple production items as Stillcanna is doing and leaving the 'shelf'/store responsibility/expense to resellers as much as possible is the way to go...
Those 'pot' stock leaders will do better simply buying produced product for markup, Isolate, than go further into debt as the CBD markets grow exponentially.
